The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Cited by (1,019)

Items 801–900 of 1,019

1. AML, ALL, and CML classification and diagnosis based on bone marrow cell morphology combined with convolutional neural network
   Furong Huang, Peiwen Guang, Fucui Li, Xuewen Liu, Weimin Zhang, Wendong Huang · 2020 · Medicine
2. Myelodysplastic syndromes with ring sideroblasts ( MDS‐RS ) and MDS /myeloproliferative neoplasm with RS and thrombocytosis ( MDS/MPN‐RS‐T ) – “ 2021 update on diagnosis, risk‐stratification, and management”
   Mrinal M. Patnaik, Ayalew Tefferi · 2021 · American Journal of Hematology
3. Trametinib for Refractory Chylous Effusions and Systemic Complications in Children with Noonan Syndrome
   Taizo A. Nakano, Alexander W. Rankin, Aparna Annam, Ann Marie Kulungowski, Leslie M. McCallen, Lauren R. S. Hill, Kathryn C. Chatfield · 2022 · The Journal of Pediatrics
4. Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL
   Aaron Thomas Gerds, Ruben A. Mesa, John M. Burke, Michael Richard Grunwald, Brady Lee Stein, Peg Squier, Jingbo Yu, Jennifer E. Hamer-Maansson, Stephen T. Oh · 2023 · Blood
5. Myeloproliferative neoplasms: from origins to outcomes
   Jyoti Nangalia, Anthony Richard Green · 2017 · Hematology
6. Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
   Caner Saygin, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Mikkael Aaron Sekeres, Betty K. Hamilton, Matt E Kalaycio, Hetty E. Carraway, Aaron Thomas Gerds, Sudipto Mukherjee, Aziz Nazha et al. · 2018 · Blood Cancer Journal
7. Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML
   Sandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, Samer S. Sansil, Anthony D. Pomicter, Maria E. Balasis, John Robinson, Jodi L. Kroeger, Qing Zhang, Yu Long Zhao et al. · 2018 · Leukemia
8. Systematic reviews of economic burden and health-related quality of life in patients with acute myeloid leukemia
   Rachel Bosshard, Karl O’Reilly, Stephen Ralston, Shkun Chadda, David Cork · 2018 · Cancer Treatment Reviews
9. Clinical Significance of DNA Variants in Chronic Myeloid Neoplasms
   Rebecca F. McClure, Mark David Ewalt, Jennifer Crow, Robyn Temple‐Smolkin, Mrudula Pullambhatla, Rachel Lynn Sargent, Annette S. Kim · 2018 · Journal of Molecular Diagnostics
10. Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia
    Lu Wang, Liyuan Yang, Zailin Yang, Yuting Tang, Yao Tao, Qian Zhan, Lei Li, Yipei Jing, Xueke Jiang, Hongjun Jin et al. · 2019 · International Journal of Biological Sciences
11. Trisomy 8 in acute myeloid leukemia
    Anette Lodvir Hemsing, Randi Hovland, Galina Tsykunova, Håkon Reikvam · 2019 · Expert Review of Hematology
12. The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations
    Anca Franzini, Anthony D. Pomicter, Dongqing Yan, Jamshid Sorouri Khorashad, Srinivas Kiran Tantravahi, Hein Than, Jonathan M. Ahmann, Thomas O’Hare, Michael W. Deininger · 2019 · Blood Advances
13. The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep
    Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Mariasanta Napolitano, Melania Carlisi, Marta Mattana, Chiara Russo, Alessandro Di Stefano, Davide Sirocchi, Sergio Mario Siragusa · 2020 · Clinical Medicine Insights Blood Disorders
14. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer
    Deepak Singhal, Christopher Norman Hahn, Simone K. Feurstein, Li Yan A. Wee, Luke Moma, Monika Kutyna, Rakchha Chhetri, Leila Eshraghi, ANDREAS W. SCHREIBER, Jinghua Feng et al. · 2021 · Leukemia
15. Bone marrow inflammation in haematological malignancies
    de Jong, Madelon M. E., Chen, Lanpeng, Raaijmakers, Marc H. G. P., Cupedo, Tom · 2024 · Nature reviews. Immunology
16. Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification
    Inge M. van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, Stephan Hütter, Constance Regina Baer, Martijn W. Heymans, Peter J.M. Valk, Wolfgang Kern, Claudia Haferlach, Jeroen J. W. M. Janssen et al. · 2021 · Blood Advances
17. Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning
    Jan‐Niklas Eckardt, Christoph Röllig, Klaus Hans Metzeler, Michael Krämer, Sebastian Stasik, Julia-Annabell Georgi, Peter Heisig, Karsten Spiekermann, Utz O. Krug, Jan Braess et al. · 2022 · Haematologica
18. Detection of acute promyelocytic leukemia in peripheral blood and bone marrow with annotation-free deep learning
    Petru Manescu, Priya Narayanan, Christopher Bendkowski, Muna Elmi, Rémy Claveau, Vijay Pawar, Biobele Jotham Brown, Michael J Shaw, Anupama Rao, Delmiro Fernández-Reyes · 2023 · Scientific Reports
19. A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents
    Nicholas James Short, Muharrem Müftüoğlu, Faustine Ong, Lewis Fady Nasr, Walid Macaron, Guillermo Montalban Bravo, Yesid Alvarado, Mahesh Basyal, Naval Guastad Daver, Courtney Denton Dinardo et al. · 2023 · Journal of Hematology & Oncology
20. Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants
    Álex Bataller, Sanam Loghavi, Yoheved S. Gerstein, Alexandre Bazinet, Koji Sasaki, Kelly Sharon Chien, Danielle E. Hammond, Guillermo Montalban Bravo, Gautam M. Borthakur, Nicholas James Short et al. · 2023 · American Journal of Hematology
21. Management of chronic myeloid leukemia in 2025
    Hagop M. Kantarjian, Massimo Breccia, Fadi Haddad, Rüdiger Hehlmann, Ghayas C. Issa, Hemant Malhotra, Franck Emmanuel Nicolini, Koji Sasaki, Leif Stenke, Elias Joseph Jabbour · 2025 · Cancer
22. Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia
    Terra L. Lasho, Christy M. Finke, Darci Zblewski, Mrinal M. Patnaik, Rhett P. Ketterling, Dong Chen, Curtis A. Hanson, Ayalew Tefferi, Animesh Dev Pardanani · 2015 · Blood Cancer Journal
23. CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse
    Roni Tamari, Stephen S. Chung, Esperanza Bouza Papadopoulos, Ann Alice Jakubowski, Patrick D. Hilden, Sean M. Devlin, Jenna D. Goldberg, Miguel‐Angel Perales, Doris M. Ponce, Craig Steven Sauter et al. · 2015 · Transplantation and Cellular Therapy
24. Treatment of low-risk myelodysplastic syndromes
    Valeria Santini · 2016 · Hematology
25. Molecular analysis of myelodysplastic syndrome with isolated deletion of the long arm of chromosome 5 reveals a specific spectrum of molecular mutations with prognostic impact: a study on 123 patients and 27 genes
    Manja Meggendorfer, Claudia Haferlach, Wolfgang Kern, Torsten Haferlach · 2017 · Haematologica
26. The biology of Philadelphia chromosome-like ALL
    Kathryn G. Roberts · 2017 · Best Practice & Research Clinical Haematology
27. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
    Kiran Tawana, Michael William Drazer, Jane E. Churpek · 2018 · Leukemia
28. EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
    Mrinal M. Patnaik, Rangit Reddy Vallapureddy, Terra L. Lasho, Katherine P. Hoversten, Christy M. Finke, Rhett P. Ketterling, Curtis A. Hanson, Naseema Gangat, Ayalew Tefferi · 2018 · Blood Cancer Journal
29. Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms
    Valerio De Stefano, Guido Finazzi, Tiziano Barbui · 2018 · Blood Cancer Journal
30. JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia
    Sangeetha Venugopal, Michal Bar‐Natan, John O Mascarenhas · 2019 · Blood Reviews
31. External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails
    Johannes Schetelig, Henning Baldauf, Falk Heidenreich, Carolin Massalski, Sandra Kay Frank, Jürgen Sauter, Matthias Stelljes, Francis Ayuketang Ayuk, Wolfgang Andreas Bethge, Gesine Bug et al. · 2020 · Blood
32. Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant
    Seongseok Yun, Onyee Chan, Daniel Alan Kerr, Nicole D. Vincelette, Afshan Idrees, Qianxing Mo, Kendra Lynn Sweet, Jeffrey E. Lancet, Mohamed A. Kharfan‐Dabaja, Ling Zhang et al. · 2020 · Blood Advances
33. Unique ethnic features of DDX41 mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia
    Eun‐Ji Choi, Young‐Uk Cho, Eun‐Hye Hur, Seongsoo Jang, Nayoung Kim, Han‐Seung Park, Jung‐Hee Lee, Kyoo‐Hyung Lee, Sihwan Kim, Sang‐Hyun Hwang et al. · 2021 · Haematologica
34. Phylogenetic reconstruction of myeloproliferative neoplasm reveals very early origins and lifelong evolution
    Nicholas Williams, Joe Lee, Luiza Moore, E. Joanna Baxter, James Hewinson, Kevin J. Dawson, Andrew H. Menzies, Anna L. Godfrey, Anthony Richard Green, Peter J. Campbell et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
35. Emergence and evolution of <i>TP53</i> mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide
    Lodé, Laurence, Ménard, Audrey, Flet, Laurent, Richebourg, Steven, Loirat, Marion, Eveillard, Marion, Le Bris, Yannick, Godon, Catherine, Theisen, Olivier, Gagez, Anne-Laure et al. · 2018 · Haematologica
36. Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia
    Gong, Z, Medeiros, L J, Cortes, J E, Zheng, L, Khoury, J D, Wang, W, Tang, G, Loghavi, S, Luthra, R, Yang, W et al. · 2017 · Blood Cancer Journal
37. Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry
    Anna Lübking, Arta Dreimane, Fredrik Sandin, Cecilia Isaksson, Berit Markevärn, Mats L. Brune, Per T Ljungman, Stig Lenhoff, Leif Stenke, Martin Höglund et al. · 2019 · Bone Marrow Transplantation
38. Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment
    Thomas Alexander, Etan Orgel · 2021 · Current Oncology Reports
39. What’s new in the pathogenesis and treatment of therapy-related myeloid neoplasms
    Maria Teresa Voso, Giulia Falconi, Emiliano Fabiani · 2021 · Blood
40. ASXL1/2 mutations and myeloid malignancies
    Edward Antonio Medina, Caroline R. Delma, Feng‐Chun Yang · 2022 · Journal of Hematology & Oncology
41. Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients
    Hosuk Ryou, Korsuk Sirinukunwattana, Alan Aberdeen, Gillian Grindstaff, Bernadette J. Stolz, Helen Mary Byrne, Heather A. Harrington, Nikolaos Sousos, Anna L. Godfrey, Claire N. Harrison et al. · 2022 · Leukemia
42. Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
    Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, Nico Gagelmann, Carmelo Gurnari, Somedeb Ball, Juan Carlos Caballero Berrocal, Luca Lanino, Saverio D’Amico, Marta Spreafico et al. · 2024 · Journal of Clinical Oncology
43. The role of the extracellular matrix in primary myelofibrosis
    Orly Leiva, Seng Kah Ng, Shlok V. Chitalia, Alessandra Balduini, Shinobu Matsuura, Katya Ravid · 2017 · Blood Cancer Journal
44. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
    Aroa Baragaño Raneros, Alfredo Minguela, Ramón María Alvargonzález Rodríguez, Enrique Colado, Teresa Bernal, Eduardo Anguita, Adela Vasco Mogorron, Alberto Chaparro, José Ramón Vidal-Castiñeira, Leonardo Márquez‐Kisinousky et al. · 2017 · Oncotarget
45. Shanghai Health Study (2001–2009): What was learned about benzene health effects?
    Sherilyn A. Gross, Dennis J. Paustenbach · 2017 · Critical Reviews in Toxicology
46. Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies
    Saikat Ghosh, Rohan Lalani, Vivek Patel, Denish Bardoliwala, Kuntal Maiti, Shubhadeep Banerjee, Subhas Bhowmick, Ambikanandan R. Misra · 2019 · Journal of Controlled Release
47. ERCC6L2 defines a novel entity within inherited acute myeloid leukemia
    Suvi P. M. Douglas, Pihla Siipola, Panu E. Kovanen, Marja Pyörälä, Sakari Kakko, Eeva‐Riitta Savolainen, Urpu Salmenniemi, Katri J. Orte, Soili I. Kytölä, Esa Pitkänen et al. · 2019 · Blood
48. Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults
    Anand Ashwin Patel, Joseph Thomas, Alexandra E. Rojek, Wendy Stock · 2020 · Current Treatment Options in Oncology
49. MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment
    Julian Grabek, Jasmin Straube, Megan J. Bywater, Steven Lane · 2020 · Cells
50. ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine
    Diletta Fontana, Mario Mauri, Rossella Renso, Mattia Docci, Ilaria Crespiatico, Lisa Marie Røst, Mi Jang, Antonio Niro, Deborah D’Aliberti, Luca Massimino et al. · 2020 · Nature Communications
51. Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)
    Yun, Seongseok, Geyer, Susan M., Komrokji, Rami S., Al Ali, Najla H., Song, Jinming, Hussaini, Mohammad, Sweet, Kendra L., Lancet, Jeffrey E., List, Alan F., Padron, Eric et al. · 2021 · Leukemia
52. Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia
    Mehrdad Hefazi, Mark Robert Litzow · 2018 · Blood and Lymphatic Cancer Targets and Therapy
53. Glasdegib Plus Intensive/Nonintensive Chemotherapy in Untreated Acute Myeloid Leukemia: BRIGHT AML 1019 Phase III Trials
    Jörge E. Cortes, Hervé Dombret, Akil Abid Merchant, Tetsuzo Tauchi, Christine DiRienzo, Barbara Sleight, Xiaoxi Zhang, Eric P. Leip, M. Naveed Shaik, TIMOTHY J. BELL et al. · 2019 · Future Oncology
54. BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
    Gunnar Cario, Veronica Leoni, Valentino Conter, André Baruchel, Martin Schrappe, Andrea Biondi · 2020 · Haematologica
55. Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
    Long Su, Yuanyuan Shi, Zengyan Liu, Sujun Gao · 2022 · Frontiers in Oncology
56. Delivery strategies in treatments of leukemia
    Tianyuan Ci, Wentao Zhang, Yingyu Qiao, Huangjuan Li, Jing Zang, Hongjun Li, Nianping Feng, Zhen Gu · 2022 · Chemical Society Reviews
57. Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy
    Katherine Tarlock, Maria Luisa Sulis, Joseph H. Chewning, Jessica Anne Pollard, Todd M. Cooper, Alan S. Gamis, Shalini S. Shenoy, Matthew A. Kutny, John Horan, Soheil Meshinchi et al. · 2022 · Transplantation and Cellular Therapy
58. Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms
    Yudi Zhang, Junying Wu, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Lijuan Pan, Bing Li, Huijun Wang, Peihong Zhang, Xin Yan et al. · 2022 · Leukemia
59. AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
    Elisabetta Todisco, Cristina Papayannidis, Nicola Fracchiolla, Elisabetta Petracci, Chiara Zingaretti, Calogero Vetro, Maria Paola Martelli, Patrizia Zappasodi, Nicola Di Renzo, Susanna Gallo et al. · 2023 · Cancer
60. Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice
    Ayalew Tefferi, Tiziano Barbui · 2015 · Mayo Clinic Proceedings
61. Implications of molecular genetic diversity in myelodysplastic syndromes
    Rafael L. Bejar · 2016 · Current Opinion in Hematology
62. Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia
    Mohamad Jawhar, Nicole Naumann, Marcin Knut, J Score, Muna Ghazzawi, Björn Schneider, K.-A. Kreuzer, Michael J. Hallek, Hans Günter Drexler, Joseph M. Chacko et al. · 2017 · Leukemia
63. Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy
    Germana Castelli, Elvira Pelosi, Ugo Testa · 2017 · OncoTargets and Therapy
64. Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis
    Ayalew Tefferi, Sahrish H Shah, Mythri Mudireddy, Terra L. Lasho, Daniela Barraco, Curtis A. Hanson, Rhett P. Ketterling, Michelle Ann Elliott, Mrinal M. Patnaik, Animesh Dev Pardanani et al. · 2017 · British Journal of Haematology
65. The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia
    Silje Johansen, Annette K. Brenner, Sushma Bartaula-Brevik, Håkon Reikvam, Øystein Bruserud · 2018 · International Journal of Molecular Sciences
66. Myeloproliferative neoplasms with concurrent BCR–ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group
    Craig R. Soderquist, Mark David Ewalt, David R. Czuchlewski, Julia Turbiner Geyer, Heesun Joyce Rogers, Eric D. Hsi, Sa A. Wang, Carlos Bueso-Ramos, Attilio Orazi, Daniel A. Arber et al. · 2018 · Modern Pathology
67. Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making
    James A. Kennedy, Gabriela Soriano Hobbs · 2018 · Current Hematologic Malignancy Reports
68. Current status and trends in the diagnostics of AML and MDS
    Evgenii Shumilov, Johanna Flach, Alexander Kohlmann, Yara Banz, Nicolas Bonadies, Martin Fiedler, Thomas Pabst, Ulrike Bacher · 2018 · Blood Reviews
69. Monosomy 7 in Pediatric Myelodysplastic Syndromes
    Marcin W. Włodarski, Sushree Sangita Sahoo, Charlotte Marie Niemeyer · 2018 · Hematology/Oncology Clinics of North America
70. Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline
    Válerie de Haas, Nofisat Ismaila, Anjali S. Advani, Daniel A. Arber, Raetasha Sheavette Dabney, Dipti Patel‐Donnelly, Elizabeth Kitlas, Rob Pieters, Ching‐Hon Pui, Kendra Lynn Sweet et al. · 2018 · Journal of Clinical Oncology
71. A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset
    Dorothée Selimoglu‐Buet, Julie Rivière, Hussein Ghamlouch, Laura Bencheikh, Catherine Lacout, Margot Morabito, M'boyba Khadija Diop, Guillaume Meurice, Marie Breckler, Aurélie Chauveau et al. · 2018 · Nature Communications
72. The Genetic and Molecular Basis for Canine Models of Human Leukemia and Lymphoma
    Anne C. Avery · 2020 · Frontiers in Oncology
73. Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post–autologous stem cell transplantation
    Johannes Frasez Soerensen, Anni Aggerholm, Gitte Birk Kerndrup, Marcus Høy Hansen, Ina Kathrine Lykke Ewald, Marie Bill, Lene Hyldahl Ebbesen, Carina Agerbo Rosenberg, Peter Hokland, Maja Ludvigsen et al. · 2020 · Blood Advances
74. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency
    Emilia J. Kozyra, Victor B. Pastor, Stylianos Lefkopoulos, Sushree Sangita Sahoo, Hauke S. Busch, Rebecca K. Voss, Miriam Erlacher, Dirk Lebrecht, Enikoe Amina Szvetnik, Shinsuke Hirabayashi et al. · 2020 · Leukemia
75. Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes
    Peter L. Greenberg, Heinz Tuechler, Julie Schanz, Guillermo Francisco Sanz, Guillermo Garcia‐Manero, Francesc Gessé Solé, John M. Bennett, David Bowen, Pierre Fenaux, François Dreyfus et al. · 2016 · Blood
76. The evolutionary history of 2,658 cancers
    Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, Stefan C. Dentro, Santiago González, Daniel Rosebrock, Thomas J. Mitchell, Yulia Rubanova, Pavana Anur, Kaixian Yu et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
77. How I investigate Eosinophilia
    Rebecca L. Larsen, Natasha M. Savage · 2018 · International Journal of Laboratory Hematology
78. Overview of Myeloproliferative Neoplasms
    Douglas A. Tremblay, Abdulraheem Yacoub, Ronald Hoffman · 2021 · Hematology/Oncology Clinics of North America
79. Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT
    Nicola Polverelli, Juan Carlos Hernández‐Boluda, Tomasz Czerw, Tiziano Barbui, Mariella D’Adda, Hans Joachim Deeg, Markus Ditschkowski, Claire N. Harrison, Nicolaus Martin Kröger, Ruben A. Mesa et al. · 2022 · The Lancet Haematology
80. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy
    Martina Ruglioni, Stefania Crucitta, Giovanna Irene Luculli, Gaspare Tancredi, Maria Livia Del Giudice, Sandra Mechelli, Sara Galimberti, Romano Danesi, Marzia Del Re · 2024 · Critical Reviews in Oncology/Hematology
81. Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome
    Moreno Benedetto Festuccia, H. Joachim Deeg, Theodore A. Gooley, Kelsey Baker, Brent Lee Wood, Min Fang, Brenda M. Sandmaier, Bart Lee Scott · 2016 · Transplantation and Cellular Therapy
82. Genomic analysis of myeloproliferative neoplasms in chronic and acute phases
    Frédéric Courtier, Nadine Carbuccia, Sèverine Garnier, Arnaud Guillé, José Adélaı̈de, Nathalie Cervera, Véronique Gelsi‐Boyer, Julien Mozziconacci, Jérôme Rey, Norbert Vey et al. · 2016 · Haematologica
83. A life‐threatening ruxolitinib discontinuation syndrome
    Giacomo Coltro, Francesco Mannelli, Paola Guglielmelli, Annalisa Pacilli, Alberto Bosi, Alessandro Maria Vannucchi · 2017 · American Journal of Hematology
84. Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms
    Prajwal Chaitanya Boddu, Lucia Masárová, Srđan Verstovšek, Paolo Strati, Hagop M. Kantarjian, Jörge E. Cortes, Zeev E. Estrov, Sherry A. Pierce, Naveen Pemmaraju · 2017 · Annals of Hematology
85. Setd2 regulates quiescence and differentiation of adult hematopoietic stem cells by restricting RNA polymerase II elongation
    Yile Zhou, Xiaomei Yan, Xiaomin Feng, Jiachen Bu, Yunzhu Dong, Peipei Lin, Yoshihiro Hayashi, Rui Huang, André Olsson, Paul R. Andreassen et al. · 2018 · Haematologica
86. Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
    Ming‐En Lin, Hsin‐An Hou, Cheng‐Hong Tsai, Shang‐Ju Wu, Yuan‐Yeh Kuo, Mei‐Hsuan Tseng, Ming-Chih Liu, Chia‐Wen Liu, Wen‐Chien Chou, Chien‐Yuan Chen et al. · 2018 · Clinical Epigenetics
87. The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms
    Manja Meggendorfer, Sabine Jeromin, Claudia Haferlach, Wolfgang Kern, Torsten Haferlach · 2018 · Haematologica
88. Mutation Profiling of Malignant Lymphoma by Next-Generation Sequencing of Circulating Cell-Free DNA
    Peng Sun, Cui Chen, Yi Xia, Yu Wang, Panpan Liu, Xi-Wen Bi, Yang Washington Shao, Qiu-Xiang Ou, Xue Wu, Hang Yang et al. · 2019 · Journal of Cancer
89. Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma
    Mojgan Djavaheri‐Mergny, Sylvie Giuriato, Mario P. Tschan, Magali Humbert · 2019 · Cells
90. Advances in biology of acute lymphoblastic leukemia (ALL) and therapeutic implications.
    Mahsa Mir Mohseni, Hasan Uludağ, Joseph M. Brandwein · 2018 · Europe PMC (PubMed Central)
91. KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease
    Michelle O. Forgione, Barbara J. McClure, Laura N Eadie, David T. O. Yeung, Deborah L. White · 2019 · Cancer Letters
92. Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow
    Étienne Paubelle, Florence Zylbersztejn, Thiago Trovati Maciel, Caroline Carvalho, Annalisa Mupo, Meyling Hua-Chen Cheok, Liesbet Lieben, Pierre Sujobert, Justine Decroocq, Akihiko Yokoyama et al. · 2020 · Cell Reports
93. Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia
    Yuling Wan, Congxiao Zhang, Yingxi Xu, Min Wang, Qing Rao, Haiyan Xing, Zheng Tian, Kejing Tang, Yingchang Mi, Ying Wang et al. · 2020 · BMC Cancer
94. Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
    Alexandra S. Higgins, Mithun Vinod Shah · 2020 · Genes
95. How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML)
    Richard James Dillon, Nicola E. Potter, Sylvie D. Freeman, Nigel H. Russell · 2020 · British Journal of Haematology
96. Cytotoxic effect of CLL‑1 CAR‑T cell immunotherapy with PD‑1 silencing on relapsed/refractory acute myeloid leukemia
    Guo‐Qiang Lin, Yanming Zhang, Lei Yu, Depei Wu · 2021 · Molecular Medicine Reports
97. Diagnostic studies of the fetus, placenta and maternal blood from 265 bovine abortions.
    IV Jerrett, S. McOrist, Josh Waddington, J. W. Browning, J. C. MALECKI, Ian P. McCausland · 1984 · PubMed
98. A decade of progress in myelodysplastic syndrome with chromosome 5q deletion
    List, Alan, Ebert, Benjamin L., Fenaux, Pierre · 2018 · Leukemia
99. Recently approved therapies in acute myeloid leukemia: A complex treatment landscape
    Chetasi Talati, Kendra Lynn Sweet · 2018 · Leukemia Research
100. Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: Epidemiology and predictors of comorbidity and deaths
     Alexander Leonardo Silva-Junior, Fabíola Silva Alves-Hanna, Marlon Wendell Athaydes Kerr, Lilyane Amorim Xábregas, Fábio Magalhães-Gama, Maria Rodrigues, Alexandre Santos Torres, Andréa Monteiro Tarragô, Vanderson de Souza Sampaio, Maria Perpétuo Socorro Sampaio Carvalho et al. · 2019 · PLoS ONE